心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 AHA科学声明：视网膜中央动脉阻塞的管理

2021-03-08 美国心脏协会 Stroke.2021 Mar 8

视网膜中央动脉阻塞

2021年3月，美国心脏协会(AHA)发布了视网膜中央动脉阻塞的管理声明。视网膜中央动脉阻塞（CRAO）是一种急性缺血性卒中，可导致严重的视力丧失，是进一步脑血管和心血管事件的先兆。本文主要诊断视网膜

中文标题：

2021 AHA科学声明：视网膜中央动脉阻塞的管理

英文标题：

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2021-03-08

简要介绍：

2021年3月，美国心脏协会(AHA)发布了视网膜中央动脉阻塞的管理声明。视网膜中央动脉阻塞（CRAO）是一种急性缺血性卒中，可导致严重的视力丧失，是进一步脑血管和心血管事件的先兆。本文主要诊断视网膜中央动脉阻塞的管理提供了一个框架。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明：视网膜中央动脉阻塞的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=35fe51c0020e6ab0, title=2021 AHA科学声明：视网膜中央动脉阻塞的管理, enTitle=Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association, guiderFrom=Stroke.2021 Mar 8, authorId=0, author=, summary=2021年3月，美国心脏协会(AHA)发布了视网膜中央动脉阻塞的管理声明。视网膜中央动脉阻塞（CRAO）是一种急性缺血性卒中，可导致严重的视力丧失，是进一步脑血管和心血管事件的先兆。本文主要诊断视网膜, cover=https://img.medsci.cn/2021330/1617115368193_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Mon Mar 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月，美国心脏协会(AHA)发布了视网膜中央动脉阻塞的管理声明。视网膜中央动脉阻塞（CRAO）是一种急性缺血性卒中，可导致严重的视力丧失，是进一步脑血管和心血管事件的先兆。本文主要诊断视网膜中央动脉阻塞的管理提供了一个框架。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=69323, tagName=视网膜中央动脉阻塞)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=69323, guiderKeyword=视网膜中央动脉阻塞, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24190, appHits=217, showAppHits=0, pcHits=1163, showPcHits=23973, likes=2, shares=11, comments=13, approvalStatus=1, publishedTime=Tue Mar 30 23:50:47 CST 2021, publishedTimeString=2021-03-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 30 22:44:37 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:08:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明：视网膜中央动脉阻塞的管理.pdf)])
2021 AHA科学声明：视网膜中央动脉阻塞的管理.pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184164, encodeId=6bb711841640a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:58:01 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085728, encodeId=19de1085e2895, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Thu Dec 30 09:30:07 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066033, encodeId=9f331066033b4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac45551317, createdName=ms6000000589844961, createdTime=Tue Nov 02 00:12:27 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009523, encodeId=ffb1100952328, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:50 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003879, encodeId=a6a210038e933, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:03:54 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2022-01-14 14700d3fm94(暂无昵称)

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184164, encodeId=6bb711841640a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:58:01 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085728, encodeId=19de1085e2895, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Thu Dec 30 09:30:07 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066033, encodeId=9f331066033b4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac45551317, createdName=ms6000000589844961, createdTime=Tue Nov 02 00:12:27 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009523, encodeId=ffb1100952328, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:50 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003879, encodeId=a6a210038e933, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:03:54 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-12-30 米师

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184164, encodeId=6bb711841640a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:58:01 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085728, encodeId=19de1085e2895, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Thu Dec 30 09:30:07 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066033, encodeId=9f331066033b4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac45551317, createdName=ms6000000589844961, createdTime=Tue Nov 02 00:12:27 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009523, encodeId=ffb1100952328, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:50 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003879, encodeId=a6a210038e933, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:03:54 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-11-02 ms6000000589844961

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184164, encodeId=6bb711841640a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:58:01 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085728, encodeId=19de1085e2895, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Thu Dec 30 09:30:07 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066033, encodeId=9f331066033b4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac45551317, createdName=ms6000000589844961, createdTime=Tue Nov 02 00:12:27 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009523, encodeId=ffb1100952328, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:50 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003879, encodeId=a6a210038e933, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:03:54 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-08-19 眼科芳

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184164, encodeId=6bb711841640a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b245183705, createdName=14700d3fm94(暂无昵称), createdTime=Fri Jan 14 09:58:01 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085728, encodeId=19de1085e2895, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Oiaecicujl2wfpBkKyhZ6gwISPy9rBt6nOxLXG0QhflNATVnicPmib6zX885nmcdZh0mEqTbaSWeftY7CcwDnSvduw/132, createdBy=bca42490282, createdName=米师, createdTime=Thu Dec 30 09:30:07 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066033, encodeId=9f331066033b4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ac45551317, createdName=ms6000000589844961, createdTime=Tue Nov 02 00:12:27 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009523, encodeId=ffb1100952328, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:50 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003879, encodeId=a6a210038e933, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:03:54 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-07-30 纪芳

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

拓展阅读

视网膜中央动脉阻塞诊疗规范：2021美国心脏协会指南解读

南昌大学第一附属医院眼科 · 2021-10-05